The present study investigated the association of the non-steroidal anti-inflammatory drug ibuprofen with itraconazole, fluconazole and amphotericin B against Cryptococcus neoformans isolates. The minimal inhibitory concentration (MIC) was found according to M27-A3 protocol and in vitro interactions were evaluated using checkerboard microdilution method. Synergism was demonstrated between azoles and ibuprofen for most isolates. However, no synergistic effects were seen when amphotericin B was combined with ibuprofen. Therefore, our results suggest that ibuprofen presents clinical potential when combined with azole drugs in the treatment of cryptococcosis
Candida albicans is the most prevalent cause of fungemia worldwide. Its ability to develop resistanc...
Background Cryptococcal meningitis has fatality rates of 40%‐70%, resulting in 200 000 deaths each y...
Amphotericin B and fluconazole are current acceptable therapies for cryptococcal meningitis; however...
The present study investigated the association of the non-steroidal anti-inflammatory drug ibuprofen...
The incidence of opportunistic human pathogen Cryptococcus neoformans caused infections have been hi...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
Objective: The prevalence of invasive mycoses is increased in the immunocompromised patients with an...
Background and objectives: The incidence of drug-resistant candidiasis has increased dramatically. T...
Ibuprofen, a non-steroidal anti-inflammatory drug, exhibited antimicrobial activity against Candida ...
Azoles are antifungal drugs used to treat fungal infections such as candidiasis in humans. Their ext...
The manifestation of disseminated cryptococcal infection in HIV-infected individual is a life-threat...
Cryptococcus neoformans infections in patients with AIDS are often incurable, despite aggressive ant...
Objectives: Resistance to antifungals often relates to efflux pumps exporting drugs; several modulat...
Treatment failures can occur in AIDS patients infected with Cryptococcus neoformans, despite aggress...
Several azoles are widely used to treat human fungal infections. Increasing resistance to these azol...
Candida albicans is the most prevalent cause of fungemia worldwide. Its ability to develop resistanc...
Background Cryptococcal meningitis has fatality rates of 40%‐70%, resulting in 200 000 deaths each y...
Amphotericin B and fluconazole are current acceptable therapies for cryptococcal meningitis; however...
The present study investigated the association of the non-steroidal anti-inflammatory drug ibuprofen...
The incidence of opportunistic human pathogen Cryptococcus neoformans caused infections have been hi...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
Objective: The prevalence of invasive mycoses is increased in the immunocompromised patients with an...
Background and objectives: The incidence of drug-resistant candidiasis has increased dramatically. T...
Ibuprofen, a non-steroidal anti-inflammatory drug, exhibited antimicrobial activity against Candida ...
Azoles are antifungal drugs used to treat fungal infections such as candidiasis in humans. Their ext...
The manifestation of disseminated cryptococcal infection in HIV-infected individual is a life-threat...
Cryptococcus neoformans infections in patients with AIDS are often incurable, despite aggressive ant...
Objectives: Resistance to antifungals often relates to efflux pumps exporting drugs; several modulat...
Treatment failures can occur in AIDS patients infected with Cryptococcus neoformans, despite aggress...
Several azoles are widely used to treat human fungal infections. Increasing resistance to these azol...
Candida albicans is the most prevalent cause of fungemia worldwide. Its ability to develop resistanc...
Background Cryptococcal meningitis has fatality rates of 40%‐70%, resulting in 200 000 deaths each y...
Amphotericin B and fluconazole are current acceptable therapies for cryptococcal meningitis; however...